$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

$nhc Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000143774918015048 Filed on August 09, 2018

Income Statement

Concept	2018 Q2	2017 Q2
Revenue	$242.1M	$238.7M
YoY Change	1.44%	4.8%
Cost Of Revenue	$145.5M	$142.7M
YoY Change	1.96%	5.63%
Gross Profit	$96.70M	$96.00M
YoY Change	0.73%	3.56%
Gross Profit Margin	39.94%	40.22%
Selling, General & Admin	$10.30M	$10.10M
YoY Change	1.98%	-1.94%
% of Gross Profit	10.65%	10.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.40M	$10.50M
YoY Change	-0.95%	11.7%
% of Gross Profit	10.75%	10.94%
Operating Expenses	$83.20M	$82.70M
YoY Change	0.6%	7.26%
Operating Profit	$12.17M	$12.14M
YoY Change	0.22%	-17.1%
Interest Expense	$1.253M	$1.219M
YoY Change	2.79%	29.82%
% of Operating Profit	10.3%	10.04%
Other Income/Expense, Net	$5.654M	$5.189M
YoY Change	8.96%	5.36%
Pretax Income	$30.27M	$17.33M
YoY Change	74.68%	-11.44%
Income Tax	$7.892M	$6.758M
% Of Pretax Income	26.07%	39.0%
Net Earnings	$22.46M	$10.66M
YoY Change	110.8%	-10.21%
Net Earnings / Revenue	9.28%	4.46%
Basic Earnings Per Share	$1.47	$0.70
Diluted Earnings Per Share	$1.47	$0.70
COMMON SHARES
Basic Shares Outstanding	15.22M	15.19M
Diluted Shares Outstanding	15.23M	15.22M

Balance Sheet

Concept	2018 Q2	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$79.39M	$209.0M
YoY Change	-62.02%	16.56%
Cash & Equivalents	$59.32M	$60.85M
Short-Term Investments	$20.06M	$148.1M
Other Short-Term Assets	$31.10M	$29.10M
YoY Change	6.87%	-5.21%
Inventory	$7.306M	$7.198M
Prepaid Expenses
Receivables	$82.23M	$79.64M
Other Receivables	$1.500M	$3.800M
Total Short-Term Assets	$317.5M	$328.7M
YoY Change	-3.42%	10.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$544.0M	$555.5M
YoY Change	-2.07%	0.4%
Goodwill	$17.60M	$17.60M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$28.00M	$36.30M
YoY Change	-22.87%	0.83%
Other Assets	$209.2M	$216.0M
YoY Change	-3.13%	-8.85%
Total Long-Term Assets	$753.3M	$771.5M
YoY Change	-2.37%	-2.38%
TOTAL ASSETS
Total Short-Term Assets	$317.5M	$328.7M
Total Long-Term Assets	$753.3M	$771.5M
Total Assets	$1.071B	$1.100B
YoY Change	-2.68%	1.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.20M	$14.70M
YoY Change	10.2%	-32.57%
Accrued Expenses	$83.40M	$78.90M
YoY Change	5.7%	1.68%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due		$3.600M
YoY Change		5.88%
Total Short-Term Liabilities	$143.0M	$137.0M
YoY Change	4.34%	-2.68%
LONG-TERM LIABILITIES
Long-Term Debt	$85.00M	$120.0M
YoY Change	-29.17%	0.0%
Other Long-Term Liabilities	$16.34M	$17.35M
YoY Change	-5.85%	-0.1%
Total Long-Term Liabilities	$101.3M	$137.4M
YoY Change	-26.22%	-0.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$143.0M	$137.0M
Total Long-Term Liabilities	$101.3M	$137.4M
Total Liabilities	$364.0M	$410.8M
YoY Change	-11.39%	47.66%
SHAREHOLDERS EQUITY
Retained Earnings	$492.4M	$401.2M
YoY Change	22.73%	5.41%
Common Stock	$152.0K	$152.0K
YoY Change	0.0%	-0.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$706.3M	$688.7M
YoY Change
Total Liabilities & Shareholders Equity	$1.071B	$1.100B
YoY Change	-2.68%	1.17%

Cashflow Statement

Concept	2018 Q2	2017 Q2
OPERATING ACTIVITIES
Net Income	$22.46M	$10.66M
YoY Change	110.8%	-10.21%
Depreciation, Depletion And Amortization	$10.40M	$10.50M
YoY Change	-0.95%	11.7%
Cash From Operating Activities	$36.10M	$27.30M
YoY Change	32.23%	23.53%
INVESTING ACTIVITIES
Capital Expenditures	-$8.400M	-$8.600M
YoY Change	-2.33%	-62.11%
Acquisitions
YoY Change
Other Investing Activities	-$2.600M	-$8.800M
YoY Change	-70.45%	238.46%
Cash From Investing Activities	-$11.00M	-$17.50M
YoY Change	-37.14%	-30.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-22.90M	-7.000M
YoY Change	227.14%	11.11%
NET CHANGE
Cash From Operating Activities	36.10M	27.30M
Cash From Investing Activities	-11.00M	-17.50M
Cash From Financing Activities	-22.90M	-7.000M
Net Change In Cash	2.200M	2.800M
YoY Change	-21.43%	-129.47%
FREE CASH FLOW
Cash From Operating Activities	$36.10M	$27.30M
Capital Expenditures	-$8.400M	-$8.600M
Free Cash Flow	$44.50M	$35.90M
YoY Change	23.96%	-19.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	nhc	Annual Excess Coverage AnnualExcessCoverage	9000000
	nhc	Annual Excess Coverage AnnualExcessCoverage	9000000
	nhc	Direct Business Coverage Statutory Limits DirectBusinessCoverageStatutoryLimits	1000000
CY2018Q2	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	1795000
CY2017Q2	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	1899000
	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	3597000
	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	3623000
	nhc	Entrance Fee Deposits Refunds EntranceFeeDepositsRefunds	-159000
	nhc	Entrance Fee Deposits Refunds EntranceFeeDepositsRefunds	-757000
CY2018Q2	nhc	Equity Securities Fv Ni Gross Unrealized Gain EquitySecuritiesFvNiGrossUnrealizedGain	105851000
CY2017Q4	nhc	Equity Securities Fv Ni Gross Unrealized Gain EquitySecuritiesFvNiGrossUnrealizedGain	108933000
CY2018Q2	nhc	Equity Securities Fv Ni Gross Unrealized Loss EquitySecuritiesFvNiGrossUnrealizedLoss	11000
CY2017Q4	nhc	Equity Securities Fv Ni Gross Unrealized Loss EquitySecuritiesFvNiGrossUnrealizedLoss	24000
CY2017Q2	nhc	Income Tax Rate Reconciliation Exercise Of Stock Options Amount IncomeTaxRateReconciliationExerciseOfStockOptionsAmount	123000
	nhc	Income Tax Rate Reconciliation Exercise Of Stock Options Amount IncomeTaxRateReconciliationExerciseOfStockOptionsAmount	244000
	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	-171000
	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	931000
CY2018Q2	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	3738000
CY2017Q2	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	3752000
	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	7446000
	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	7611000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.54
CY2018Q2	nhc	Miscellaneous Revenue MiscellaneousRevenue	242000
CY2017Q2	nhc	Miscellaneous Revenue MiscellaneousRevenue	256000
	nhc	Miscellaneous Revenue MiscellaneousRevenue	579000
	nhc	Miscellaneous Revenue MiscellaneousRevenue	638000
	nhc	Noncontrolling Interest Increase From Capital Contribution NoncontrollingInterestIncreaseFromCapitalContribution	970000
CY2018Q2	nhc	Number Of Assisted Living Facilities NumberOfAssistedLivingFacilities	24
CY2018Q2	nhc	Number Of Beds NumberOfBeds	9629
CY2018Q2	nhc	Number Of Homecare Programs NumberOfHomecarePrograms	36
CY2018Q2	nhc	Number Of Independent Living Facilities NumberOfIndependentLivingFacilities	5
CY2018Q2	nhc	Number Of Skilled Nursing Centers NumberOfSkilledNursingCenters	76
CY2018Q2	nhc	Other Revenues OtherRevenues	11488000
CY2017Q2	nhc	Other Revenues OtherRevenues	11610000
	nhc	Other Revenues OtherRevenues	22757000
	nhc	Other Revenues OtherRevenues	22894000
	nhc	Primary Insurance Coverage Amount Per Incident PrimaryInsuranceCoverageAmountPerIncident	1000000
	nhc	Primary Insurance Coverage Amount Per Location PrimaryInsuranceCoverageAmountPerLocation	3000000
CY2018Q2	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1
CY2017Q2	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1
	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1
	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1
CY2018Q2	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	17218000
CY2017Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	17389000
CY2018Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	199624000
CY2017Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	197453000
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	68842000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	77657000
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	65862000
CY2018Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	16166000
CY2017Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	15978000
CY2018Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	82230000
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	86767000
CY2018Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	55688000
CY2017Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	67102000
CY2018Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	430014000
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	409429000
CY2018Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3555000
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	67504000
CY2018Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	217296000
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	215659000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	832000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1177000
CY2018Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	749000
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	740000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1177000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	832000
CY2018Q2	us-gaap	Assets Assets	1070749000
CY2017Q4	us-gaap	Assets Assets	1096526000
CY2018Q2	us-gaap	Assets Current AssetsCurrent	317494000
CY2017Q4	us-gaap	Assets Current AssetsCurrent	329311000
CY2018Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	110000
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	823000
CY2018Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4609000
CY2017Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1705000
CY2018Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	169448000
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	167277000
CY2018Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	300965000
CY2017Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	305480000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	76943000
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	80101000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	70331000
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	78615000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	70157000
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	1845000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	797000
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	1845000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	796000
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	18660000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	18492000
CY2018Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	18627000
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	18499000
CY2018Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	164949000
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	166395000
CY2018Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	20064000
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	21012000
CY2018Q2	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	144885000
CY2017Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	145383000
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15225654
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15212133
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	152000
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	152000
CY2018Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21822000
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	18694000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	16812000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	30855000
CY2018Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-86000
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-86000
CY2018Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3808000
CY2017Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3696000
CY2018Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	21120000
CY2017Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	23052000
CY2018Q2	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	29467000
CY2018Q2	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	5200000
CY2018Q2	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	5200000
CY2018Q2	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	5200000
CY2018Q2	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	5200000
CY2018Q2	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	5200000
CY2018Q2	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	3467000
CY2018Q2	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	4539000
CY2018Q2	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	24928000
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59322000
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59118000
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	60848000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67421000
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31589000
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68871000
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66596000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1450000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	35007000
CY2018Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.50
CY2017Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.48
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.98
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.93
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15225654
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15212133
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-194000
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-181000
CY2018Q2	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	2887000
CY2017Q4	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	2887000
CY2018Q2	us-gaap	Costs And Expenses CostsAndExpenses	229977000
CY2017Q2	us-gaap	Costs And Expenses CostsAndExpenses	226557000
	us-gaap	Costs And Expenses CostsAndExpenses	457055000
	us-gaap	Costs And Expenses CostsAndExpenses	449231000
CY2018Q2	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
CY2018Q2	us-gaap	Customer Refundable Fees CustomerRefundableFees	8668000
CY2017Q4	us-gaap	Customer Refundable Fees CustomerRefundableFees	8827000
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	25000
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	238000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2376000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1540000
CY2018Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	4621000
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3226000
CY2018Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	15240000
CY2017Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	18376000
CY2018Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	5849000
CY2017Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4867000
CY2018Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10397000
CY2017Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10481000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20739000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20776000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20739000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20776000
	us-gaap	Dividends Common Stock DividendsCommonStock	14125000
	us-gaap	Dividends Common Stock DividendsCommonStock	14917000
CY2018Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	7612000
CY2017Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	7297000
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.48
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.70
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.54
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.47
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.70
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2018Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.261
CY2017Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.39
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.294
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.389
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.032
CY2018Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	6329000
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P4Y
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	3741000
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	4337000
CY2018Q2	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	12448000
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-3069000
CY2017Q2	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss
CY2018Q2	us-gaap	Goodwill Goodwill	17600000
CY2017Q4	us-gaap	Goodwill Goodwill	17600000
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	30267000
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	17327000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	27568000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	37959000
CY2018Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2001000
CY2017Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1854000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4584000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3380000
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7892000
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6758000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8092000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14757000
CY2017	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	-8488000
CY2017Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	84000
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	881000
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	133400
CY2017Q2	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	146200
	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	321000
CY2018Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable
CY2017Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	5465000
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	188000
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-3855000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4537000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2891000
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-11414000
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-12601000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1395000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1524000
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-418000
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-5465000
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-2218000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	153000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-310000
CY2017Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1436000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	3576000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	2954000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1048000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1551000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	969000
	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	1538000
	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	3379000
CY2018Q2	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	1955000
CY2017Q2	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	2087000
CY2018Q2	us-gaap	Inventory Net InventoryNet	7306000
CY2017Q4	us-gaap	Inventory Net InventoryNet	7153000
CY2018Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	28014000
CY2017Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	36339000
	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	3646000
	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	3644000
CY2018Q2	us-gaap	Interest Expense InterestExpense	1253000
CY2017Q2	us-gaap	Interest Expense InterestExpense	1219000
	us-gaap	Interest Expense InterestExpense	2493000
	us-gaap	Interest Expense InterestExpense	2277000
CY2018Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1858000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1386000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1440000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	540000
CY2018Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	145466000
CY2017Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	142684000
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	285561000
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	280739000
CY2018Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10272000
CY2017Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10079000
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	20501000
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	20167000
CY2018Q2	us-gaap	Liabilities Liabilities	363979000
CY2017Q4	us-gaap	Liabilities Liabilities	393094000
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1070749000
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1096526000
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	142993000
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	155065000
CY2018Q2	us-gaap	Long Term Debt LongTermDebt	85000000
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	100000000
CY2018Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent
CY2018Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	85000000
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	100000000
CY2018Q1	us-gaap	Malpractice Loss Contingency Number Of Claims MalpracticeLossContingencyNumberOfClaims	63
CY2018Q2	us-gaap	Malpractice Loss Contingency Number Of Claims MalpracticeLossContingencyNumberOfClaims	63
CY2018Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	136016000
CY2017Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	139085000
CY2018Q2	us-gaap	Minority Interest MinorityInterest	500000
CY2017Q4	us-gaap	Minority Interest MinorityInterest	694000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-31121000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-14073000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16802000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	8775000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	49373000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	40305000
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	22461000
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	10655000
	us-gaap	Net Income Loss NetIncomeLoss	19670000
	us-gaap	Net Income Loss NetIncomeLoss	23383000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-181000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-194000
CY2018Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-86000
CY2017Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-86000
CY2018Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1499000
CY2017Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1450000
CY2018Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	10952000
CY2017Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	11801000
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2018Q2	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	10
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	12165000
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	12138000
	us-gaap	Operating Income Loss OperatingIncomeLoss	28048000
	us-gaap	Operating Income Loss OperatingIncomeLoss	28002000
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	296450000
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	34200000
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	34200000
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	34200000
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	34200000
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	34200000
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	125450000
CY2018Q2	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	5553000
CY2017Q2	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	5515000
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	11086000
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8039000
CY2018Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	14000
CY2017Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	204000
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	25000
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	238000
CY2018Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	209220000
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	217896000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7472000
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2858000
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-639000
CY2018Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-169000
CY2017Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	5054000
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-759000
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	4646000
CY2018Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-794000
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	13297000
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	11001000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-3592000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	12356000
CY2018Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	62589000
CY2017Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	62094000
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	127761000
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	125272000
CY2018Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14808000
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	16194000
CY2018Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16335000
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15795000
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5654000
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5189000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2589000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9957000
CY2017	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	867000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	14602000
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	13649000
	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates
	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	176000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15456000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16681000
	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	6545000
	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	22775000
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3428000
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2864000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;">Prior Period Classifications</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">Certain amounts in prior periods have been reclassified to conform with current period presentation.</div></div></div>
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	800000
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	3651000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1327000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1496000
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	970000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	4399000
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	44756000
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	4399000
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	44756000
CY2018Q2	us-gaap	Profit Loss ProfitLoss	22375000
CY2017Q2	us-gaap	Profit Loss ProfitLoss	10569000
	us-gaap	Profit Loss ProfitLoss	19476000
	us-gaap	Profit Loss ProfitLoss	23202000
CY2018Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	974049000
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	958748000
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	544035000
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	549319000
CY2018Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1064000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2023000
CY2017Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1055000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2233000
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	25000
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	238000
	us-gaap	Repayments Of Debt RepaymentsOfDebt	15000000
	us-gaap	Repayments Of Debt RepaymentsOfDebt
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1820000
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	1715000
CY2018Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	9549000
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5748000
CY2018Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	7629000
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	6397000
CY2018Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1920000
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1906000
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	492377000
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	419423000
	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">D</div><div style="display: inline; font-style: italic;">eferred Revenue </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">Deferred revenue includes the deferred gain on the sale of assets to National Health Corporation (“National”), the non-refundable portion (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div>) of CCRC entrance fees being amortized over the remaining life expectancies of the residents, and premiums received within our workers’ compensation and professional liability companies that are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> yet earned.</div></div></div>
CY2018Q2	us-gaap	Revenues Revenues	242142000
CY2017Q2	us-gaap	Revenues Revenues	238695000
	us-gaap	Revenues Revenues	485103000
	us-gaap	Revenues Revenues	477233000
CY2018Q2	us-gaap	Self Insurance Reserve SelfInsuranceReserve	94808000
CY2017Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	93275000
CY2018Q2	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	27693000
CY2017Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	27409000
CY2018Q2	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	67115000
CY2017Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	65866000
	us-gaap	Share Based Compensation ShareBasedCompensation	1177000
	us-gaap	Share Based Compensation ShareBasedCompensation	832000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0329
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.031
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.161
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.166
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0246
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0208
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	15000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	20000
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	72.94
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	72.94
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1125443
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	111240
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2167000
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	177959
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1239407
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1297121
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	55.48
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	71.19
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	70.84
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1613000
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	210881
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	63.35
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	51.25
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	51.25
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	72.96
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	61.40
CY2018Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1297121
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y292D
CY2018Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	70.84
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y219D
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	48995
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	33526
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1496000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1327000
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	706270000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	702738000
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	669611000
CY2017Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	689458000
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	703432000
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	706770000
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	867000
	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;">Estimates and Assumptions</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and could cause our reported net income to vary significantly from period to period.</div></div></div>
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15228305
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15220448
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15224958
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15216336
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15221262
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15189818
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15218962
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15181700

Files In Submission

Name	View Source	Status
0001437749-18-015048-index-headers.html	Edgar Link	pending
0001437749-18-015048-index.html	Edgar Link	pending
0001437749-18-015048.txt	Edgar Link	pending
0001437749-18-015048-xbrl.zip	Edgar Link	pending
a1.jpg	Edgar Link	pending
ex_119657.htm	Edgar Link	pending
ex_119658.htm	Edgar Link	pending
ex_119659.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nhc-20180630.xml	Edgar Link	completed
nhc-20180630.xsd	Edgar Link	pending
nhc-20180630_cal.xml	Edgar Link	unprocessable
nhc-20180630_def.xml	Edgar Link	unprocessable
nhc-20180630_lab.xml	Edgar Link	unprocessable
nhc-20180630_pre.xml	Edgar Link	unprocessable
nhc20180630_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

2018 Q2 Form 10-Q Financial Statement

#000143774918015048 Filed on August 09, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC NATIONAL HEALTHCARE CORP Stock $nhc

2018 Q2 Form 10-Q Financial Statement

#000143774918015048 Filed on August 09, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc